Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00701103
Brief Title: Dose Escalation Trial of Dalotuzumab (MK-0646) in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001)

First Submitted : June 17, 2008
First Submitted that Met QC Criteria : June 18, 2008
First Posted : June 19, 2008 (Estimate)

Results First Submitted : January 31, 2017
Results First Submitted that Met QC Criteria : January 31, 2017
Results First Posted : March 21, 2017

Last Update Submitted that Met QC Criteria : July 12, 2018
Last Update Posted : August 8, 2018